 | • レポートコード：MRC2-11QY13570 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は急性感音難聴治療のグローバル市場について調査・分析したレポートです。種類別（全身ステロイド、抗ウイルス薬、血管拡張薬、炭素療法、その他）市場規模、用途別（病院、耳科クリニック、外来クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別急性感音難聴治療の競争状況、市場シェア ・世界の急性感音難聴治療市場：種類別市場規模 2015年-2020年（全身ステロイド、抗ウイルス薬、血管拡張薬、炭素療法、その他） ・世界の急性感音難聴治療市場：種類別市場規模予測 2021年-2026年（全身ステロイド、抗ウイルス薬、血管拡張薬、炭素療法、その他） ・世界の急性感音難聴治療市場：用途別市場規模 2015年-2020年（病院、耳科クリニック、外来クリニック） ・世界の急性感音難聴治療市場：用途別市場規模予測 2021年-2026年（病院、耳科クリニック、外来クリニック） ・北米の急性感音難聴治療市場分析：米国、カナダ ・ヨーロッパの急性感音難聴治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの急性感音難聴治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の急性感音難聴治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの急性感音難聴治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Bristol-Myers Squibb Company、Allergan、Renate pharmaceutical、Merck、F. Hoffmann-La Roche、Eli Lilly and Company、Novartis、GlaxoSmithKline、Teva pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Acute Sensorineural hearing loss is also known as sudden hearing loss involves an acute unexplained sensorineural hearing loss. Acute Sensorineural hearing loss hearing loss is defined as more than 30 dB hearing decline, over at least three contiguous frequencies, occurring over a period of 72 hours or less. Mostly occur in one ear and its affects the inner ear. Ear infection, high noise, disruption in eardrum, viral infection, and various other causes are responsible for acute sensorineural hearing loss. Many diagnosis tools are available to identify or detect the acute sensorineural hearing loss. According to ASLHA, in America yearly estimated incidence of acute sensorineural hearing loss is 5 to 20 cases per 100,000 individual.
Due to rapidly growing incidence of acute sensorineural hearing loss, rising aging population, increasing noise pollution are the driver for the acute sensorineural hearing loss treatment market and other driving forces are innovation and advancement in acute sensorineural hearing loss treatment therapeutic. However, the lack of diagnostic tools and less awareness of acute sensorineural hearing hamper Acute Sensorineural Hearing Loss treatment Market.
Market Analysis and Insights: Global Acute Sensorineural Hearing Loss Treatment Market
The global Acute Sensorineural Hearing Loss Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Acute Sensorineural Hearing Loss Treatment Scope and Market Size
Acute Sensorineural Hearing Loss Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Sensorineural Hearing Loss Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Bristol-Myers Squibb Company
Allergan
Renate pharmaceutical
Merck
F. Hoffmann-La Roche
Eli Lilly and Company
Novartis
GlaxoSmithKline
Teva pharmaceuticals
Market segment by Type, the product can be split into
Systemic Steroids
Antiviral Medication
Vasodilators
Carbogen Therapy
Others
Market segment by Application, split into
Hospitals
Otology Clinics
Ambulatory Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Sensorineural Hearing Loss Treatment Revenue
1.4 Market by Type
1.4.1 Global Acute Sensorineural Hearing Loss Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Systemic Steroids
1.4.3 Antiviral Medication
1.4.4 Vasodilators
1.4.5 Carbogen Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Acute Sensorineural Hearing Loss Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Otology Clinics
1.5.4 Ambulatory Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Acute Sensorineural Hearing Loss Treatment Market Perspective (2015-2026)
2.2 Global Acute Sensorineural Hearing Loss Treatment Growth Trends by Regions
2.2.1 Acute Sensorineural Hearing Loss Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Sensorineural Hearing Loss Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Acute Sensorineural Hearing Loss Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Sensorineural Hearing Loss Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Sensorineural Hearing Loss Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acute Sensorineural Hearing Loss Treatment Players by Market Size
3.1.1 Global Top Acute Sensorineural Hearing Loss Treatment Players by Revenue (2015-2020)
3.1.2 Global Acute Sensorineural Hearing Loss Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Sensorineural Hearing Loss Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Sensorineural Hearing Loss Treatment Market Concentration Ratio
3.2.1 Global Acute Sensorineural Hearing Loss Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Sensorineural Hearing Loss Treatment Revenue in 2019
3.3 Acute Sensorineural Hearing Loss Treatment Key Players Head office and Area Served
3.4 Key Players Acute Sensorineural Hearing Loss Treatment Product Solution and Service
3.5 Date of Enter into Acute Sensorineural Hearing Loss Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Acute Sensorineural Hearing Loss Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acute Sensorineural Hearing Loss Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
5.2 Global Acute Sensorineural Hearing Loss Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acute Sensorineural Hearing Loss Treatment Market Size (2015-2020)
6.2 Acute Sensorineural Hearing Loss Treatment Key Players in North America (2019-2020)
6.3 North America Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020)
6.4 North America Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acute Sensorineural Hearing Loss Treatment Market Size (2015-2020)
7.2 Acute Sensorineural Hearing Loss Treatment Key Players in Europe (2019-2020)
7.3 Europe Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020)
7.4 Europe Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
8 China
8.1 China Acute Sensorineural Hearing Loss Treatment Market Size (2015-2020)
8.2 Acute Sensorineural Hearing Loss Treatment Key Players in China (2019-2020)
8.3 China Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020)
8.4 China Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acute Sensorineural Hearing Loss Treatment Market Size (2015-2020)
9.2 Acute Sensorineural Hearing Loss Treatment Key Players in Japan (2019-2020)
9.3 Japan Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020)
9.4 Japan Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size (2015-2020)
10.2 Acute Sensorineural Hearing Loss Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
11 India
11.1 India Acute Sensorineural Hearing Loss Treatment Market Size (2015-2020)
11.2 Acute Sensorineural Hearing Loss Treatment Key Players in India (2019-2020)
11.3 India Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020)
11.4 India Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acute Sensorineural Hearing Loss Treatment Market Size (2015-2020)
12.2 Acute Sensorineural Hearing Loss Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Acute Sensorineural Hearing Loss Treatment Introduction
13.1.4 Pfizer Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Bristol-Myers Squibb Company
13.2.1 Bristol-Myers Squibb Company Company Details
13.2.2 Bristol-Myers Squibb Company Business Overview
13.2.3 Bristol-Myers Squibb Company Acute Sensorineural Hearing Loss Treatment Introduction
13.2.4 Bristol-Myers Squibb Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.2.5 Bristol-Myers Squibb Company Recent Development
13.3 Allergan
13.3.1 Allergan Company Details
13.3.2 Allergan Business Overview
13.3.3 Allergan Acute Sensorineural Hearing Loss Treatment Introduction
13.3.4 Allergan Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.3.5 Allergan Recent Development
13.4 Renate pharmaceutical
13.4.1 Renate pharmaceutical Company Details
13.4.2 Renate pharmaceutical Business Overview
13.4.3 Renate pharmaceutical Acute Sensorineural Hearing Loss Treatment Introduction
13.4.4 Renate pharmaceutical Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.4.5 Renate pharmaceutical Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Acute Sensorineural Hearing Loss Treatment Introduction
13.5.4 Merck Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.5.5 Merck Recent Development
13.6 F. Hoffmann-La Roche
13.6.1 F. Hoffmann-La Roche Company Details
13.6.2 F. Hoffmann-La Roche Business Overview
13.6.3 F. Hoffmann-La Roche Acute Sensorineural Hearing Loss Treatment Introduction
13.6.4 F. Hoffmann-La Roche Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.6.5 F. Hoffmann-La Roche Recent Development
13.7 Eli Lilly and Company
13.7.1 Eli Lilly and Company Company Details
13.7.2 Eli Lilly and Company Business Overview
13.7.3 Eli Lilly and Company Acute Sensorineural Hearing Loss Treatment Introduction
13.7.4 Eli Lilly and Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.7.5 Eli Lilly and Company Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Acute Sensorineural Hearing Loss Treatment Introduction
13.8.4 Novartis Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Details
13.9.2 GlaxoSmithKline Business Overview
13.9.3 GlaxoSmithKline Acute Sensorineural Hearing Loss Treatment Introduction
13.9.4 GlaxoSmithKline Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.9.5 GlaxoSmithKline Recent Development
13.10 Teva pharmaceuticals
13.10.1 Teva pharmaceuticals Company Details
13.10.2 Teva pharmaceuticals Business Overview
13.10.3 Teva pharmaceuticals Acute Sensorineural Hearing Loss Treatment Introduction
13.10.4 Teva pharmaceuticals Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020)
13.10.5 Teva pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Acute Sensorineural Hearing Loss Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Sensorineural Hearing Loss Treatment Revenue
Table 3. Ranking of Global Top Acute Sensorineural Hearing Loss Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Sensorineural Hearing Loss Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Systemic Steroids
Table 6. Key Players of Antiviral Medication
Table 7. Key Players of Vasodilators
Table 8. Key Players of Carbogen Therapy
Table 9. Key Players of Others
Table 10. Global Acute Sensorineural Hearing Loss Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Acute Sensorineural Hearing Loss Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Acute Sensorineural Hearing Loss Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Acute Sensorineural Hearing Loss Treatment Market Share by Regions (2015-2020)
Table 14. Global Acute Sensorineural Hearing Loss Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Acute Sensorineural Hearing Loss Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Acute Sensorineural Hearing Loss Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Acute Sensorineural Hearing Loss Treatment Players
Table 21. Global Acute Sensorineural Hearing Loss Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Acute Sensorineural Hearing Loss Treatment Market Share by Players (2015-2020)
Table 23. Global Top Acute Sensorineural Hearing Loss Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Sensorineural Hearing Loss Treatment as of 2019)
Table 24. Global Acute Sensorineural Hearing Loss Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Acute Sensorineural Hearing Loss Treatment Product Solution and Service
Table 27. Date of Enter into Acute Sensorineural Hearing Loss Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Acute Sensorineural Hearing Loss Treatment Market Size Share by Type (2015-2020)
Table 31. Global Acute Sensorineural Hearing Loss Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Acute Sensorineural Hearing Loss Treatment Market Size Share by Application (2015-2020)
Table 33. Global Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Acute Sensorineural Hearing Loss Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2019-2020)
Table 37. North America Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Acute Sensorineural Hearing Loss Treatment Market Share by Type (2015-2020)
Table 39. North America Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Acute Sensorineural Hearing Loss Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2019-2020)
Table 43. Europe Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Acute Sensorineural Hearing Loss Treatment Market Share by Type (2015-2020)
Table 45. Europe Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Acute Sensorineural Hearing Loss Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2019-2020)
Table 49. China Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Acute Sensorineural Hearing Loss Treatment Market Share by Type (2015-2020)
Table 51. China Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Acute Sensorineural Hearing Loss Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2019-2020)
Table 55. Japan Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Acute Sensorineural Hearing Loss Treatment Market Share by Type (2015-2020)
Table 57. Japan Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Acute Sensorineural Hearing Loss Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2019-2020)
Table 61. Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2019-2020)
Table 67. India Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Acute Sensorineural Hearing Loss Treatment Market Share by Type (2015-2020)
Table 69. India Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Acute Sensorineural Hearing Loss Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Acute Sensorineural Hearing Loss Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Acute Sensorineural Hearing Loss Treatment Market Share (2019-2020)
Table 73. Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Acute Sensorineural Hearing Loss Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Acute Sensorineural Hearing Loss Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Acute Sensorineural Hearing Loss Treatment Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Bristol-Myers Squibb Company Company Details
Table 83. Bristol-Myers Squibb Company Business Overview
Table 84. Bristol-Myers Squibb Company Product
Table 85. Bristol-Myers Squibb Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Allergan Company Details
Table 88. Allergan Business Overview
Table 89. Allergan Product
Table 90. Allergan Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 91. Allergan Recent Development
Table 92. Renate pharmaceutical Company Details
Table 93. Renate pharmaceutical Business Overview
Table 94. Renate pharmaceutical Product
Table 95. Renate pharmaceutical Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 96. Renate pharmaceutical Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Product
Table 100. Merck Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 101. Merck Recent Development
Table 102. F. Hoffmann-La Roche Company Details
Table 103. F. Hoffmann-La Roche Business Overview
Table 104. F. Hoffmann-La Roche Product
Table 105. F. Hoffmann-La Roche Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 106. F. Hoffmann-La Roche Recent Development
Table 107. Eli Lilly and Company Company Details
Table 108. Eli Lilly and Company Business Overview
Table 109. Eli Lilly and Company Product
Table 110. Eli Lilly and Company Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 111. Eli Lilly and Company Recent Development
Table 112. Novartis Business Overview
Table 113. Novartis Product
Table 114. Novartis Company Details
Table 115. Novartis Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 116. Novartis Recent Development
Table 117. GlaxoSmithKline Company Details
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Product
Table 120. GlaxoSmithKline Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 121. GlaxoSmithKline Recent Development
Table 122. Teva pharmaceuticals Company Details
Table 123. Teva pharmaceuticals Business Overview
Table 124. Teva pharmaceuticals Product
Table 125. Teva pharmaceuticals Revenue in Acute Sensorineural Hearing Loss Treatment Business (2015-2020) (Million US$)
Table 126. Teva pharmaceuticals Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Sensorineural Hearing Loss Treatment Market Share by Type: 2020 VS 2026
Figure 2. Systemic Steroids Features
Figure 3. Antiviral Medication Features
Figure 4. Vasodilators Features
Figure 5. Carbogen Therapy Features
Figure 6. Others Features
Figure 7. Global Acute Sensorineural Hearing Loss Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Otology Clinics Case Studies
Figure 10. Ambulatory Clinics Case Studies
Figure 11. Acute Sensorineural Hearing Loss Treatment Report Years Considered
Figure 12. Global Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Acute Sensorineural Hearing Loss Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Acute Sensorineural Hearing Loss Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Acute Sensorineural Hearing Loss Treatment Market Share by Players in 2019
Figure 17. Global Top Acute Sensorineural Hearing Loss Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Sensorineural Hearing Loss Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Acute Sensorineural Hearing Loss Treatment Revenue in 2019
Figure 19. North America Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Acute Sensorineural Hearing Loss Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
レーザー脱毛治療の世界市場（～2026年） Laser devices used for hair loss treatments are non-invasive treatment devices. These devices use low level lasers technology (LLLT) for hair loss treatments. These are also known as soft lasers or cold lasers. These lasers penetrate the scalp and stimulate the roots of hair, which increases blood c…- 脱毛症（脱毛）治療の世界市場（～2026年） Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues. Changing lifestyle along with increase in stress level among working class population is expected to boost the demand for treatment of hair loss globally. Furthermore, rise in geriatrics pop…
- 人工内耳インプラントの世界市場（～2026年） Hearing implants are an option when conventional hearing aids no longer give enough benefit. Implants are designed for different types of hearing loss. They are surgically implanted devices which can give you the sensation of sound. The increasing prevalence of hearing loss as one of the primary fac…
- 補聴器・聴覚装置の世界市場（～2026年） Market Analysis and Insights: Global Hearing Aids and Audiology Devices Market The global Hearing Aids and Audiology Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hearing Aids and Audiology Devices Scope and …
- 補聴器の世界市場（～2026年） Market Analysis and Insights: Global Hearing Aid Devices Market The global Hearing Aid Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hearing Aid Devices Scope and Market Size Hearing Aid Devices market is seg…